Across TCGA pan-cancer cohorts, MIR548F2 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR548F2 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher MIR548F2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR548F2 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

UCS, HNSC, and GBM are the cancer types where MIR548F2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.104	0.688	<.001	108	view →
HNSC	OS	Tertile	All	0.222	0.687	.020	99	view →
GBM	DFS	Tertile	All	0.085	0.291	.014	18	view →
ESCA	DFS	Tertile	III,IV	1.000	0.281	.043	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR548F2 tumor-vs-normal RNA expression · all MIR548F2 data types